Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Mogamulizumab can cause hair loss and skin rashes.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Hyaluronic acid filler can safely and effectively improve facial contour in Parry-Romberg Syndrome.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.